Prostate Cancer Drug Breakthrough For Aggressive Form Of Disease

Medical News Today: "A new trial drug called abiraterone has shown a high success rate at treating men with an aggressive, drug resistant, and often fatal form of prostate cancer. 70 to 80 per cent of the men on the trial experienced dramatic reductions in PSA (a protein marker for prostate cancer) and tumour shrinkage, even in tumours that had spread to bone and other tissue.

The study, which is published in the 21st July online issue of the Journal of Clinical Oncology, was the work of researchers based at the Institute of Cancer Research (where the drug was discovered) and The Royal Marsden Hospital in London, and funded by Cougar Biotechnology, Inc of Los Angeles, California."